Certified by Founder Lodge
Forbion
Netherlands - Naarden
INVESTOR
1 Disclosed Funding Rounds $12,500,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Forbion was born out of ABN AMRO Capital Life Sciences, the latter being co-founded by Sander Slootweg, Martien van Osch and Bart Bergstein in 2000. Six years later, we transitioned to Forbio
| Company | Date | Round | Raised |
|---|---|---|---|
 Seamless Therapeutics |
March, 17 ,2023 | Series A | $12,500,000 |
 Complement Therapeutics |
April, 18 ,2023 | Series A | $78,929,000 |
 AAVantgarde Bio |
June, 07 ,2023 | Series A | $65,333,745 |
 Mariana Oncology |
September, 08 ,2023 | Series B | $175,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Scorability | $11,000,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
